Arcturus Therapeutics Holdings (ARCT) Retained Earnings (2018 - 2025)
Arcturus Therapeutics Holdings (ARCT) has disclosed Retained Earnings for 8 consecutive years, with -$514.6 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Retained Earnings fell 14.66% year-over-year to -$514.6 million, compared with a TTM value of -$514.6 million through Dec 2025, down 14.66%, and an annual FY2025 reading of -$514.6 million, down 14.66% over the prior year.
- Retained Earnings was -$514.6 million for Q4 2025 at Arcturus Therapeutics Holdings, down from -$485.5 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$200.2 million in Q1 2021 and bottomed at -$514.6 million in Q4 2025.
- Average Retained Earnings over 5 years is -$384.2 million, with a median of -$396.7 million recorded in 2022.
- The sharpest move saw Retained Earnings plummeted 177.78% in 2021, then increased 27.92% in 2023.
- Year by year, Retained Earnings stood at -$347.5 million in 2021, then increased by 2.69% to -$338.1 million in 2022, then decreased by 8.79% to -$367.9 million in 2023, then decreased by 22.0% to -$448.8 million in 2024, then fell by 14.66% to -$514.6 million in 2025.
- Business Quant data shows Retained Earnings for ARCT at -$514.6 million in Q4 2025, -$485.5 million in Q3 2025, and -$472.1 million in Q2 2025.